Abstract:Nitric oxide (NO), generated from l-arginine by endothelial nitric oxide synthase (eNOS), is a key endothelial-derived factor whose bioavailability is essential to the normal function of the endothelium. Endothelium dysfunction is characterized by loss of NO bioavailability because of either reduced formation or accelerated degradation of NO. We have recently reported that overexpression of vascular cytochrome P-450 (CYP) 4A in rats caused hypertension and endothelial dysfunction driven by increased production of 20-hydroxyeicosatetraenoic acid (20-HETE), a major vasoconstrictor eicosanoid in the microcirculation. To further explore cellular mechanisms underlying CYP4A-20-HETE-driven endothelial dysfunction, the interactions between 20-HETE and the eNOS-NO system were examined in vitro. Addition of 20-HETE to endothelial cells at concentrations as low as 1 nM reduced calcium ionophore-stimulated NO release by 50%. This reduction was associated with a significant increase in superoxide production. The increase in superoxide in response to 20-HETE was prevented by NG-nitro-l-arginine methyl ester, suggesting that uncoupled eNOS is a source of this superoxide. The response to 20-HETE was specific in that 19-HETE did not affect NO or superoxide production, and, in fact, the response to 20-HETE could be competitively antagonized by 19(R)-HETE. 20-HETE had no effect on phosphorylation of eNOS protein at serine-1179 or threonine-497 following addition of calcium ionophore; however, 20-HETE inhibited association of eNOS with 90-kDa heat shock protein (HSP90). In vivo, impaired acetylcholine-induced relaxation in arteries overexpressing CYP4A was associated with a marked reduction in the levels of phosphorylated vasodilator-stimulated phosphoprotein, an indicator of bioactive NO, that was reversed by inhibition of 20-HETE synthesis or action. Because association of HSP90 with eNOS is critical for eNOS activation and coupled enzyme activity, inhibition of this association by 20-HETE may underlie the mechanism, at least in part, by which increased CYP4A expression and activity cause endothelial dysfunction.

Anti-inflammatory Properties of Cytochrome P450 Epoxygenase-Derived Eicosanoids.

Increased Epoxyeicosatrienoic Acids May Be Part of a Protective Mechanism in Human Ulcerative Colitis, with Increased CYP2J2 and Reduced Soluble Epoxide Hydrolase Expression.

Eets Alleviate Ox-Ldl-Induced Inflammation by Inhibiting Lox-1 Receptor Expression in Rat Pulmonary Arterial Endothelial Cells

Cyclic AMP-dependent Modulation of Cardiac L-type Ca2+ and Transient Outward K+ Channel Activities by Epoxyeicosatrienoic Acids.

EETs Attenuate Ox-LDL-Induced LTB4 Production and Activity by Inhibiting P38 MAPK Phosphorylation and 5-LO/BLT1 Receptor Expression in Rat Pulmonary Arterial Endothelial Cells

Epoxyeicosatrienoic acids and soluble epoxide hydrolase in physiology and diseases of the central nervous system

Epoxyeicosatrienoic Acids Attenuate Cigarette Smoke Extract-Induced Interleukin-8 Production in Bronchial Epithelial Cells

Role of epoxyeicosatrienoic acids in cardiovascular diseases and cardiotoxicity of drugs

Up-regulation of endothelial nitric-oxide synthase by endothelium-derived hyperpolarizing factor involves mitogen-activated protein kinase and protein kinase C signaling pathways.

Cytochrome P-450 Epoxygenases Protect Endothelial Cells from Apoptosis Induced by Tumor Necrosis Factor-Alpha Via Mapk and Pi3k/Akt Signaling Pathways

The Antiinflammatory Effect Of Laminar Flow: The Role Of Ppar Gamma, Epoxyeicosatrienoic Acids, And Soluble Epoxide Hydrolase

Abstract 973: Angiotensin II Up-Regulates Soluble Epoxide Hydrolase in Vascular Endothelial Cells

CYP2J2 targeting to endothelial cells attenuates adiposity and vascular dysfunction in mice fed a high-fat diet by reprogramming adipocyte phenotype

Soluble Epoxide Hydrolase: a Promising Therapeutic Target for Cardiovascular Diseases.

The Functions of Cytochrome P450 ω-hydroxylases and the Associated Eicosanoids in Inflammation-Related Diseases

20-Hydroxyeicosatetraenoic Acid Causes Endothelial Dysfunction Via Enos Uncoupling

CYP2J2 Overexpression Increases EETs and Protects Against Angiotensin II-induced Abdominal Aortic Aneurysm in Mice

The involvement of soluble epoxide hydrolase in the development of cardiovascular diseases through epoxyeicosatrienoic acids

Biological Roles of 5-Oxo-6,8,11,14-Eicosatetraenoic Acid and the OXE Receptor in Allergic Diseases: Collegium Internationale Allergologicum Update 2024

Epoxyeicosatrienoic Acids Inhibit the Activation of NLRP3 Inflammasome in Murine Macrophages.

Arachidonic Acid Cytochrome P450 Epoxygenases Protect Vessel Endothelial Cells Against Apoptosis Induced by Tumor Necrosis Factor-Α